For the Inventor, By the Inventor

Enter assignee name

La Jolla, CA, United States of America

Sibia Neurosciences, Inc.

USPTO Granted Patents = 48

Forward Citations = 634

Loading Chart...

Loading Chart...

34 inventors (with patents filed for the assignee):

Steven B Ellis (19 out of 40 patents)

Michael Miller Harpold (19 out of 46 patents)

Ian A McDonald (12 out of 57 patents)

4. Mark E Williams (10 out of 24 patents)

5. Robert Brenner (9 out of 13 patents)

6. Nicholas David Cosford (9 out of 16 patents)

7. Elisabeth Albrecht (8 out of 14 patents)

8. Benito Munoz (8 out of 9 patents)

9. Ann F McCue (6 out of 11 patents)

10. Jeffrey Paul Whitten (6 out of 68 patents)

11. Daniel H Feldman (5 out of 8 patents)

12. Lorrie P Daggett (5 out of 17 patents)

13. Jean-Michel Andre Vernier (5 out of 56 patents)

14. Gonul Velicelebi (4 out of 29 patents)

15. Paul Brust (4 out of 14 patents)

Core Competencies:

Protease Inhibitors

Calcium Channels

Acetylcholine Receptors

Neurodegenerative Disorders

Human Receptors

Automated Assays

Nucleic Acids

Peptide Analog

Bioassays

Modulators

Genetic Compositions

Cell Surface Detection

48 patents: Sort by Forward Citations

1. 6153171 - Methods for identifying compounds effective for treating (2000-11-28),

2. 6127133 - Automated analysis equipment and assay method for detecting cell surface (2000-10-03),

3. 6096514 - Human calcium channel compositions and methods (2000-08-01),

4. 6057114 - Automated assays and methods for detecting and modulating cell surface (2000-05-02),

5. 6051684 - Methods of treating neurodegenerative disorders using protease inhibitors (2000-04-18),

6. 6051419 - Genes which influence pichia proteolytic activity, and uses therefor (2000-04-18),

7. 6033865 - Human n-methyl-d-aspartate receptor type 1 subunits, DNA encoding same (2000-03-07),

8. 6022704 - DNA and mRNA encoding an .alpha..sub.4 subunit of human neuronal (2000-02-08),

9. 6017887 - Peptide, peptide analog and amino acid analog protease inhibitors (2000-01-25),

10. 6015879 - Peptide and peptide analog protease inhibitors (2000-01-18),

11. 6013474 - Calcium channel compositions and methods (2000-01-11),

12. 6001581 - Cation-based bioassay using human metabotropic glutamate receptors (1999-12-14),

13. 5985586 - Methods for identifying compounds that modulate the activity of human (1999-11-16),

14. 5981193 - Human neuronal nicotinic acetylcholine receptor compositions and methods (1999-11-09),

15. 5969100 - Peptide, peptide analog and amino acid analog protease inhibitors (1999-10-19),

Company Overview

Sibia Neurosciences, Inc., based in La Jolla, CA, focuses on developing innovative solutions for neurodegenerative disorders. The company specializes in a range of technologies, including protease inhibitors and bioassays that leverage calcium channels and nicotinic acetylcholine receptors. Sibia's research extends to metabotropic glutamate receptors and peptide analogues, aiming to advance therapeutic options in neuroscience. Their automated assays facilitate high-throughput screening, contributing to the understanding and treatment of complex neurological conditions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

48 Patents

#14 in La Jolla, CA

#1,714 in California

#7,265 in US

#14,536 in the World

La Jolla, CA, United States of America

Sibia Neurosciences, Inc.

Forward Citations = 634

34 inventors:

Steven B Ellis (19 out of 40 patents)

Michael Miller Harpold (19 out of 46 patents)

Ian A McDonald (12 out of 57 patents)

4. Mark E Williams (10 out of 24 patents)

5. Robert Brenner (9 out of 13 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Sibia Neurosciences, Inc.. Retrieved from https://idiyas.com/company/sibia-neurosciences

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…